Digitalized Clinical Decision Support for the Prevention of Postoperative Delirium (POD)
Launched by CHARITE UNIVERSITY, BERLIN, GERMANY · Jun 5, 2024
Trial Information
Current as of May 18, 2025
Recruiting
Keywords
ClinConnect Summary
The Digitalized Clinical Decision Support for the Prevention of Postoperative Delirium (POD) trial is designed to enhance patient safety and improve care for older adults who are undergoing elective surgeries. The goal is to implement better guidelines that can help prevent postoperative delirium, a condition where patients may become confused or disoriented after surgery. This study is currently recruiting participants, specifically focusing on patients aged 70 and older who are insured through public health insurance and can provide consent. Family members aged 18 and older may also participate by giving consent on behalf of the patient.
If you or a family member are eligible and choose to participate, you can expect to be involved in a program that aims to streamline the care process and reduce the workload for healthcare providers. This means that not only will patients receive better support before and after their surgery, but it also helps healthcare teams work more efficiently. It’s important to know that participants will need to understand the study well and provide consent, and those with language barriers or serious health issues may not be eligible. Overall, this trial seeks to close gaps in care and ensure a safer, more effective experience for patients during their surgical journey.
Gender
ALL
Eligibility criteria
- Study patients:
- Inclusion Criteria:
- • Age ≥ 70 years
- • Male and female patients
- • Patients who are insured through statutory health insurance
- • Patients capable of giving consent for inclusion: by the patient, preoperatively
- • Patients under guardianship for inclusion: written declaration of consent by guardian
- • Operation (elective)
- Exclusion Criteria:
- • Insufficient language skills
- • Moribund patients
- • Study relatives
- Inclusion Criteria:
- • Age ≥ 18 years
- • Male and female relatives
- • Relatives capable of giving consent for inclusion
- Exclusion Criteria:
- • Insufficient language skills
- • No consent for data entry
- Substudy of the Charité - University Berlin:
- Inclusion criteria:
- • - All inpatients ≥ 18 years of age who have undergone delirium screening with a validated delirium screening instrument
About Charite University, Berlin, Germany
Charité - Universitätsmedizin Berlin is a leading academic medical center in Germany, renowned for its commitment to excellence in research, education, and patient care. As one of Europe's largest university hospitals, Charité integrates cutting-edge clinical practices with innovative research initiatives, fostering interdisciplinary collaboration across various medical fields. The institution is dedicated to advancing healthcare through rigorous clinical trials, contributing to the development of new therapies and treatment protocols. With a strong emphasis on translational medicine, Charité aims to bridge the gap between scientific discovery and practical application, ultimately enhancing patient outcomes and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Berlin, , Germany
Berlin, , Germany
Bad Oeynhausen, Bochum, Germany
Berlin, , Germany
Patients applied
Trial Officials
Claudia Spies, MD, Prof.
Study Director
Charite University, Berlin, Germany
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported